Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis and biological evaluation of novel indazole-based derivatives as potent HDAC inhibitors via fragment-based virtual screening
Jian Liu, Jingxian Zhou, Feng-Jun He, et al.
European Journal of Medicinal Chemistry (2020) Vol. 192, pp. 112189-112189
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Medicinal chemistry updates of novel HDACs inhibitors (2020 to present)
Xingrui He, Zi Hui, Li Xu, et al.
European Journal of Medicinal Chemistry (2021) Vol. 227, pp. 113946-113946
Closed Access | Times Cited: 57
Emerging therapeutic strategies in cancer therapy by HDAC inhibition as the chemotherapeutic potent and epigenetic regulator
Dipanjan Karati, Swarupananda Mukherjee, Souvik Roy
Medical Oncology (2024) Vol. 41, Iss. 4
Closed Access | Times Cited: 11
Small-molecule inhibitors of breast cancer-related targets: Potential therapeutic agents for breast cancer
Tingting Liu, Shubin Song, Xu Wang, et al.
European Journal of Medicinal Chemistry (2020) Vol. 210, pp. 112954-112954
Closed Access | Times Cited: 59
Dynamics-Based Discovery of Novel, Potent Benzoic Acid Derivatives as Orally Bioavailable Selective Estrogen Receptor Degraders for ERα+ Breast Cancer
Xiaomeng Zhang, Shaobin Wang, Xue Li, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 11, pp. 7575-7595
Closed Access | Times Cited: 33
Recent Progress in Histone Deacetylase (HDAC) 1 Inhibitors as Anticancer Agent
Preeti Patel, Simranpreet K. Wahan, S. Vishakha, et al.
Current Cancer Drug Targets (2022) Vol. 23, Iss. 1, pp. 47-70
Closed Access | Times Cited: 24
Design, synthesis and biological evaluation of dual Topo II/HDAC inhibitors bearing pyrimido[5,4-b]indole and pyrazolo[3,4-d]pyrimidine motifs
Mengmiao Zhao, Kan Yang, Xinyue Zhu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 252, pp. 115303-115303
Closed Access | Times Cited: 15
Discovery of 1,6-Naphthyridin-2(1H)-one Derivatives as Novel, Potent, and Selective FGFR4 Inhibitors for the Treatment of Hepatocellular Carcinoma
Xiaomeng Zhang, Shaobin Wang, Jianfeng Ji, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 11, pp. 7595-7618
Closed Access | Times Cited: 19
Heterocycles‐Containing HDAC Inhibitors Active in Cancer: An Overview of the Last Fifteen Years
A. Russo Raucci, Carola Castiello, Antonello Mai, et al.
ChemMedChem (2024)
Open Access | Times Cited: 4
Design, synthesis and biological evaluation of novel imidazole-based benzamide and hydroxamic acid derivatives as potent histone deacetylase inhibitors and anticancer agents
Mahda Sadat Nasrollahzadeh, Vahid Eskandarpour, Mahdi Faal Maleki, et al.
Journal of Molecular Structure (2023) Vol. 1297, pp. 136951-136951
Closed Access | Times Cited: 10
Suberoylanilide Hydroxamic Acid Analogs with Heteroaryl Amide Group and Different Chain Length: Synthesis and Effect on Histone Deacetylase
Gabriele Micheletti, Carla Boga, Giacomo Drius, et al.
Molecules (2024) Vol. 29, Iss. 1, pp. 238-238
Open Access | Times Cited: 3
Discovery and identification of potential anti-melanogenic active constituents of Bletilla striata by zebrafish model and molecular docking
Yiyuan Luo, Juan Wang, Shuo Li, et al.
BMC Complementary Medicine and Therapies (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Hydroxamic acid hybrids: Histone deacetylase inhibitors with anticancer therapeutic potency
Yuan Jiang Pan, Haodong Hou, Bo Zhou, et al.
European Journal of Medicinal Chemistry (2023) Vol. 262, pp. 115879-115879
Closed Access | Times Cited: 8
Recent developments of hydroxamic acid hybrids as potential anti-breast cancer agents
Xinran Cao, Yufeng Gong
Future Medicinal Chemistry (2024) Vol. 16, Iss. 5, pp. 469-492
Open Access | Times Cited: 2
Design, synthesis, and biological evaluation of novel nicotinamide derivatives as potential histone deacetylase-3 inhibitors
Mohamed M. S. Hamoud, Sravani Pulya, Nermine A. Osman, et al.
New Journal of Chemistry (2020) Vol. 44, Iss. 23, pp. 9671-9683
Closed Access | Times Cited: 20
Importance of Indazole against Neurological Disorders
Dilipkumar Pal, Pooja Sahu
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 14, pp. 1136-1151
Closed Access | Times Cited: 11
1H-Indazoles derivatives targeting PI3K/AKT/mTOR pathway: Synthesis, anti-tumor effect and molecular mechanism
Shuai Wang, Jian-Tao Shi, Xingrong Wang, et al.
Bioorganic Chemistry (2023) Vol. 133, pp. 106412-106412
Closed Access | Times Cited: 6
Histone deacetylase‑2: A potential regulator and therapeutic target in liver disease (Review)
Yurong Liu, Jiequan Wang, Zhaogang Huang, et al.
International Journal of Molecular Medicine (2021) Vol. 48, Iss. 1
Open Access | Times Cited: 13
Methods for the synthesis of 1H-pyrazolo[3,4-b]pyridine derivatives
Аndrey V. Smolobochkin, Almir S. Gazizov, A. R. Garifzyanov, et al.
Russian Chemical Bulletin (2022) Vol. 71, Iss. 5, pp. 878-884
Closed Access | Times Cited: 8
Discovery of novel class of histone deacetylase inhibitors as potential anticancer agents
Raafat El‐Awady, Ekram Saleh, Rifat Hamoudi, et al.
Bioorganic & Medicinal Chemistry (2021) Vol. 42, pp. 116251-116251
Open Access | Times Cited: 10
Synthesis of benzoxazole-based vorinostat analogs and their antiproliferative activity
Christiana Mantzourani, Dimitrios Gkikas, Alexandros C. Kokotos, et al.
Bioorganic Chemistry (2021) Vol. 114, pp. 105132-105132
Closed Access | Times Cited: 10
Competitive routes to cyclizations of polyfluoroalkyl-containing 2-tolylhydrazinylidene-1,3-diketones with 3-aminopyrazoles into bioactive pyrazoloazines
Natalia А. Elkina, Yanina V. Burgart, Evgeny V. Shchegolkov, et al.
Journal of Fluorine Chemistry (2020) Vol. 240, pp. 109648-109648
Closed Access | Times Cited: 8
Cascade Synthesis of Kinase-Privileged 3-Aminoindazoles via Intramolecular N–N Bond Formation
Wenyong Zhu, Andreas Krämer, Stefan Knapp, et al.
The Journal of Organic Chemistry (2022) Vol. 87, Iss. 5, pp. 3856-3862
Closed Access | Times Cited: 5
Investigation on Photophysical, Solvatochromism and Biological Significance of Substituted 2H‐Indazole Derivatives
A. Roniboss, Kaushik Chanda, M. M. Balamurali
ChemistrySelect (2020) Vol. 5, Iss. 25, pp. 7505-7516
Closed Access | Times Cited: 6
Antiproliferative and apoptotic activity of new indazole derivatives as potential anticancer agents
Fatima Laghchioua, Assoman Kouakou, Mohammed Eddahmi, et al.
Archiv der Pharmazie (2020) Vol. 353, Iss. 12
Closed Access | Times Cited: 6
Identification of novel and potent dual-targeting HDAC1/SPOP inhibitors using structure-based virtual screening, molecular dynamics simulation and evaluation of in vitro and in vivo antitumor activity
Yingxue Yang, Shutong Chen, Qinghua Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top